Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Different Influenza Vaccine Strategies in Older Adults in a Repeated Vaccination Setting
NCT07838298Phase 4Recruiting
- Sponsor
- Korea University Guro Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 4 trial of influenza vaccine and influenza vaccine, adjuvanted in influenza (4 arms), sponsored by Korea University Guro Hospital. Primary endpoints: Geometric mean titers of hemagglutination inhibition antibodies at 3 years and Geometric mean fold rise in hemagglutination inhibition antibody titers at 3 years. Started Sep 2026; status: recruiting.
02
Drugs
influenza vaccineinfluenza vaccine, adjuvanted
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07838298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07838298.